Geodon
Geodon (ziprasidone) is an atypical antipsychotic medication that works by modulating the activity of dopamine and serotonin receptors in the brain. It is primarily prescribed to manage symptoms of schizophrenia and bipolar I disorder. Proper absorption of the oral capsules requires ingestion with a full meal.
Dosage by Body Weight
Oral capsules must be taken with a meal of at least 500 calories to ensure adequate absorption. The typical starting dose for adults is 20 mg to 40 mg twice daily, which may be adjusted by a physician up to a maximum of 80 mg twice daily. Intramuscular injection is reserved for acute agitation and is administered by a healthcare professional.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients under 10 years of age have not been established. Not indicated for infants.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients under 10 years of age have not been established.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients under 10 years of age have not been established.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients under 10 years of age have not been established.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients under 10 years of age have not been established. Pediatric dosing for bipolar I disorder is typically restricted to patients 10 to 17 years old.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients under 10 years of age have not been established. Not indicated for infants. |
| 5-7 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients under 10 years of age have not been established. |
| 8-10 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients under 10 years of age have not been established. |
| 11-15 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients under 10 years of age have not been established. |
| 16-20 kg | Not recommended | N/A | Safety and effectiveness in pediatric patients under 10 years of age have not been established. Pediatric dosing for bipolar I disorder is typically restricted to patients 10 to 17 years old. |
Formulation
Purpose
Treatment of schizophrenia, acute manic or mixed episodes associated with bipolar I disorder, and acute agitation in patients with schizophrenia.
Generic Name
ZiprasidoneScheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.